BRIEF-Pfizer says EMA acceptance for Trumenba marketing authorization application review

* Pfizer announces European Medicines Agency acceptance for

review of marketing authorization application for Trumenba

(Meningococcal Group B Vaccine)

Source text for Eikon:

Further company coverage:

Read more